期刊文献+

应用果蝇S2细胞高效表达甲型H1N1流感病毒可溶性HA蛋白及其活性分析 被引量:1

Soluble expression of A/H1N1 influenza virus HA with Drosophila S2 cell line and its bio-activity identification
原文传递
导出
摘要 目的应用果蝇s2细胞表达甲型H1Nl流感病毒可溶性HA蛋白,并评估其免疫活性。方法以甲型H1N1流感A/Shenzhen/7I/09病毒株作为模版,采用RT-PCR技术扩增HA基因,构建持续性表达载体pAC5.1-HA,协同筛选载体pCoblast共转染至s2细胞,通过Blasticindin抗生素筛选获得稳定转染的s2细胞株。利用WesternBlot技术鉴定细胞上清HA蛋白表达,使用Ni亲和柱纯化重组HA蛋白。使用HA免疫BALB/c小鼠3次,利用ELISA检测HA特异性抗体效价。结果成功克隆A/Shenzhen/7I/09HA基因,长度约1.7×10^3bp。将HA基因克隆入pAC5.1-V5/His载体,经过转染、抗生素筛选后获得稳定表达HA的s2细胞株,目的蛋白以分泌形式表达于上清,相对分子质量约75×10^3D。免疫小鼠后可诱导机体产生抗HA特异性抗体,免疫后10d、30d效价分别为1:1280、1:5120。结论获得可溶性表达的HA蛋白,并具有良好的免疫活性,为后期流感免疫诊断试剂的研制、亚单位疫苗的开发、单克隆抗体的制备奠定了基础。 Objective To express soluble HA of A/H1N1 influenza virus in drosophila S2 cell line and identify its bio-activity. Methods HA gene was amplified from A/Shenzhen/71/09 virus strain using RT-PCR,then we constructed pAC5.1-HA expression vector, which was co-trausfected into S2 cell with pCoblast vector. After transfection,stable S2 cell was selected through Blasticindin. HA in the supernatant was identified with Western Blot assay and purified with Ni-column. Recombinant HA was immunized into BALB/c mice 3 times,and the Abs titers were evaluated with ELISA. Results We successfully cloned HA gene with 1.7 x 10^3 bp of A/Shenzhen/71/09 virus strain and got recombinant pAC5.1-HA expression vector. Stable S2 cell line was established after transfection and selection,which continuously expressed HA with molecular weight 75 x 10^3 D. After immunization with HA, the Abs titers were 1 : 1280 and 1 : 5120 respectively on 10 d, 30 d. Conclusion We expressed soluble HA with good bio-aetivity,which contributed to research on immune diagnosis,subunit vaccine,and monoclonal Abs for influenza.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2013年第5期360-362,共3页 Chinese Journal of Experimental and Clinical Virology
基金 深圳市新发传染病临床重点专科,深圳市科技计划项目(201202063) 东莞市科技计划项目(200910815229)
关键词 果蝇属 流感病毒A型 血凝素类 Drosophila Influenza A virus Hemagglutinins
  • 相关文献

参考文献5

  • 1Biere B,Schweiger B, Nitsche A. Influenza A H1NI diagnostics: the first, the fastest, and the most reliable. Lancet Infect Dis, 2009,9:721-722.
  • 2张国良,周伯平,陈心春,蔡车国,陆坚,杨桂林,聂广,周保罗.整合深圳人源H5N1禽流感病毒株血凝素蛋白的假型逆转录病毒的构建[J].中华微生物学和免疫学杂志,2009,29(1):53-57. 被引量:3
  • 3Job ER,Deng YM,Barfod KK,et al. Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of HINI 2009 pandemic viruses. J Immunol,2013, 190:2169-2177.
  • 4Yang L,Song Y,Li X,et al. HIV-1 virus-like particles produced by stably transfeeted Drosophila S2 cells: a desirable vaccine component. J Virol,2012,86:7662-7676.
  • 5Wang L,Hu H, Yang J, et al. High yield of human monoclonal antibody produced by stably transfected Drosophila schneider 2 cells in perfusion culture using wave bioreactor. Mol Biotechnol, 2012,52 : 170-179.

二级参考文献12

  • 1刘水腾,周伯平,杨大国,邱晨,黎毅敏,傅应云,陆普选,吴诗品,杨桂林,单万水,袁静,陈心春,王火生,钟南山.深圳市首例H5N1型人禽流感临床报告[J].中华传染病杂志,2007,25(1):29-32. 被引量:8
  • 2Briggs JA, Wilk T, Fuller SD. Do lipid rafts mediate virus assembly and pseudotyping ? J General Virol,2003,84(4) :757-768.
  • 3Moore M J, Dorfman T, Li W, et al. Retroviruses pseudotype with the severe acute respiratory syndrome coronavirus spike protein efficiently infect ceils expressing angiotensin-converting enzyme 2. J Viro1,2004,78 ( 19 ) : 10628-10635.
  • 4Wool-Lewis R J, Bates P. Characterization of Ebola virus entry by using pseudotype viruses identification of receptor deficient cell Lines. J Virol, 1998, 72(4) : 3155-3160.
  • 5Hoffmann E, Stech J, Guan Y, et al. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol, 2001,146(12) :2275-2289.
  • 6Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. PNAS, 1996,93 ( 21 ) : 11400- 11406.
  • 7Sambrook J, Fritsch EF, Maniates T. Molecular cloning: A laboratory manual. 2 nd ed. New York:Cold Spring Harbor Laboratory Press, 1998: 366-373.
  • 8Perdue ML, Suarez DL. Structural features of the avian influenza virus hemagglutinin that influence virulence. Vet Microbiol, 2000,74(2) :77-86.
  • 9Giroglou T, Cinatl JJ, Rabenau H, et al. Retroviral vectors pseudotype with severe acute respiratory syndrome coronavirus S protein. J Virol,2004,78(17) :9007-9015.
  • 10Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med,2003,197 (5) :633-642.

共引文献2

同被引文献8

  • 1Morens DM ,Fauci AS. The 1918 influenza pandemic:insights for the 21st century. J Infect Dis,2007,195 : 1018-1028.
  • 2Yen C, Hyde TB, Costa AJ, ct al. The development of global vaccine stockpiles. Lancet Infect Dis,2015 15:340-347.
  • 3Peter P, Tumpey TM, Bu F, et al. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of HgN2 influenza virus induce protective immune responses in BALB/c mice. Vaccine, 2005,23 : 5751-5759.
  • 4Nelson MI,Stratton J, Killian ML, et al. Continual reintroduction of human pandemic H1NI influenza A viruses into swine in the United States,2009 to 2014. J Virol,2015 ,89 :6218-5226.
  • 5Galarza JM, Latham T, Cupo A. Virus-like particle(VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol,2005 ,18 :244-251.
  • 6Crevar CJ,Ross TM. Elieitation of protective immune responses using a bivalent H5N1 VLP vaccine. Virol J,2008,5:131-136.
  • 7Latham T, Galarza J. Formation of wild-type and chimeric influenza virus-Like particles following simultaneous expression of only four structural proteins. J Virol,2001,75 :6154-5165.
  • 8Johansson DX, Drakenberg K, Hopmann KH, et al. Efficient expression of recombinant human monoclonal antibodies in Drosophila $2 ceils. J Immunol Methods,2007,318:37-46.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部